Kenny Walter

Investigators examine data from 13,200 adolescents to discover the association between bullying perpetration with internalizing problems.

In a new study, investigators examine how cognitive behavioral therapy used with antidepressants result in a reduction of depressive episode recurrence.

In a new trial, investigators find glecaprevir and pibrentasvir is safe to treatment HCV patients who failed treatment with an NS5A inhibitor.

In a new study, investigators find that good dietary habits do not necessarily reduce the risk of dementia later in life.

Lenard Adler, MD, talks about some of the advances in recent years in screening for ADHD in adults and adolescents.

How PTSD care can be, and should be, individualized for particular patient needs.

Arjun Masurkar, MD, PhD, previews some of the new medications that could help treat Alzheimer disease, while reviewing some of the advancements of the last decade.

In a study based in Finland, investigators link different types of oral antibiotics to an increased risk of Parkinson disease.

Michael Spigler, vice president of Patient Services and Kidney Disease Education for the American Kidney Fund, talks about the challenges and future of nephrology during Kidney Week.

Investigators examine how different supplementation impacts kidney function in patients with type 2 diabetes.

New data suggests that bipolar disorder 1 is linked with longer sleep durations, while bipolar disorder II is tied to insomnia.

In a presentation at AHA, T. Jared Bunch, MD, discusses how early detection of AF could yield positive results down the line for patients.

The approval allows Medtronic to move forward with the IN.PACT AV balloon to treat failing arteriovenous access for patients with end-stage renal disease undergoing dialysis.

The new approval grants BD the ability to move forward with a new device aimed at repairing abdominal hernias.

In a presentation during AHA, Kevin Trulock, MD, explains some of the major risk factors that contribute to atrial fibrillation.

During AHA, investigators suggest ways to improve care for women in regard to diabetic and cardiovascular interventions.

In a presentation during AHA, present recommendations for improving cardiovascular outcomes and healthy aging.

Investigators look at whether there are cardiovascular risks involved in electronic cigarettes.

During AHA, investigators analyzed some of the differences in outcomes for men and women in hypertension drug trials.

Investigators present data from the CREDENCE trial during AHA.

In a presentation during AHA, investigators present new evidence linking sleep issues with poorer outcomes for hypertension patients.

The FDA gives a green light to MiSight, a single use, contact lens to slow the progression of nearsightedness in children.

Studies are ongoing to test the safety and efficacy of treating primary hyperoxaluria type 1 patients with lumasiran.

George Mulligan, PhD, discusses during Kidney Week the results of a phase IIa study showing potential in a new drug to treat patients at risk for developing an acute kidney injury following cardiovascular surgery.

George Bakris, MD, discusses how nephrologists can work with other specialists and what the highlight of Kidney Week was.

Todd Alexander, MD, discusses a relatively new field of nephrology research during Kidney Week.

George Bakris, MD, discusses the major study during Kidney Week, as well as what diseases should get more attention in future research.

During Kidney Week, Katherine Tuttle, MD, discusses the plethora of options available to nephrologists, including dulaglutide.

In a study presented at Kidney Week, investigators breakdown data on the end-of-life care for non-dialysis veterans with chronic kidney disease.

Matthew Weir, MD talks about some of the challenges in nephrology and what has people buzzing while at Kidney Week.